Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's disease: A GISC study

American Journal of Gastroenterology

Volumn 95, Issue 6, 2000, Pages 1486-1490

  Frieri, G ⁱ   Pimpo, M T ^a   Palumbo, G ^a   Tonelli, F ^b   Annese, V ^c   Sturniolo, G C ^d   Andreoli, A ^e   Comberlato, M ^f   Corrao, G ^g   Caprilli, R ^h  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c S Giovanni Rotondo   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^f Ospedale di Bolzano   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON BIOPSY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DRUG ABSORPTION; DRUG TISSUE LEVEL; ELECTROCHEMICAL DETECTION; END TO END ANASTOMOSIS; END TO SIDE ANASTOMOSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ILEUM MUCOSA; INTESTINE ENDOSCOPY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; SIDE TO SIDE ANASTOMOSIS; SINGLE BLIND PROCEDURE;

ADULT; ANASTOMOSIS, SURGICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROHN DISEASE; FEMALE; HUMANS; ILEITIS; ILEUM; INTESTINAL MUCOSA; MALE; MESALAMINE; MIDDLE AGED; OSMOLAR CONCENTRATION; TISSUE DISTRIBUTION;

EID: 0034046259     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)00875-3     Document Type: Article

References (32)

1. Farmer R.G., Whelan G., Fazio V.W. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. Gastroenterology. 88:1985;1818-1825.
2. Tytgat G.N.J., Mulder C.J.J., Brummelkamp W.H. Endoscopic lesions in Crohn's disease early after ileocecal resection. Endoscopy. 20:1988;260-262.
3. Rutgeerts P., Geboes K., Vantrappen G., et al. Predictability of the postoperative course of Crohn's disease. Gastroenterology. 99:1990;956-963.
4. Olaison G., Smedh K., Sjodahl R. Natural course of Crohn's disease after ileocolic resection Endoscopically visualized ileal ulcers preceding symptoms . Gut. 33:1992;331-335.
5. Michelassi F., Balestracci T., Chappell R., et al. Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg. 214:1991;230-240.
6. Goldberg P.A., Wright J.P., Gerber M., et al. Incidence of surgical resection for Crohn's disease. Dis Colon Rectum. 36:1993;736-739.
7. Sustento-Reodica N., Ruiz P., et al. Recurrent Crohn's disease in transplanted bowel. Lancet. 349:1997;688-691.
8. Caprilli R., Andreoli A., Capurso L., et al. Oral masalazine (5-aminosalicylic acid; ASACOL) for the prevention of post-operative recurrence of CD. Aliment Pharmacol Ther. 8:1994;35-43.
9. Mc Leod R.S., Wolff B.G., Steinhart A.H., et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology. 109:1995;404-413.
10. Brignola C., Cottone M., Pera A., et al. Mesalamine in the prevention of endoscopic recurrence after intestinal resection for Crohn's disease. Gastroenterology. 108:1995;345-349.
11. Sutherland L.R., Martin F., Bailey R.J., et al. A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. Gastroenterology. 112:1997;1069-1077.
12. Lochs H., Mayer M., Fleig W.E., et al. Prophylaxis of post-operative relapse in Crohn's disease with 5-Aminosalicylic acid (Pentasa) in comparison to placebo. Gastroenterology. 112:1997;A1027.
13. Cammà C., Giunta M., Rosselli M., et al. 5-aminosalicylic acid (5-Aminosalicylic acid) in the maintenance treatment of Crohn's disease. A meta-analysis adjusted for confounding variables. Gastroenterology. 113:1997;1465-1473.
14. Caprilli R., Corrao G., Taddei G., et al. Prognostic factors for postoperative recurrence of Crohn's disease. Dis Colon Rectum. 39:1996;335-341.
15. Cameron J.L., Hamilton S.R., Coleman J., et al. Patterns of ileal recurrence in Crohn's disease. A prospective randomized study. Ann Surg. 215:1992;546-552.
16. Scott N.A., Sue-Ling H.M., Hughes L.E. Anastomotic configuration does not affect recurrence of Crohn's disease after ileocolonic resection. Int J Colorect Dis. 10:1995;67-69.
17. Borley N.R., Mortensen N.J., Jewell D.P. Preventing postoperative recurrence of Crohn's disease. Br J Surg. 84:1997;1493-1502.
18. Frieri G., Pimpo M.T., Andreoli A., et al. Prevention of postoperative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Aliment Pharmacol Ther. 13:1999;577-582.
19. Rutgeerts P., Geboes K., Vantrappen G., et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut. 25:1984;665-672.
20. Palumbo G., Carlucci G., Mazzeo P., et al. Simultaneous determination of 5-aminosalicylic acid, acetyl-5-aminosalicylic acid and 2,5-dihydroxybenzoic acid in endoscopic intestinal biopsy samples in humans by high-performance liquid chromatography with electrochemical detection. J Pharm Biomed Anal. 14:1995;175-180.
21. Brogden R.N., Sorkin E.M. 5-Aminosalicylic acid A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease . Drug. 38:1989;500-523.
22. Uchiyama M., Iwafuchi M., Matsuda Y., et al. Intestinal motility after massive small bowel resection in conscious Canines comparison of acute and chronic phases . J Pediatr Gastroenterol Nutr. 23:1996;217-223.
23. Galligan J.J., Furness J.B., Costa M. Migration of the myoelectric complex after interruption of the myenteric plexus Intestinal transection and regeneration of enteric nerves in the guinea pig . Gastroenterology. 97:1989;1135-1146.
24. Johnson C.P., Sarna S.K., Cowles V.E., et al. Effects of transection and reanastomosis on postprandial jejunal transit and contractile activity. Surgery. 117:1995;531-537.
25. Hocking M.P., Carlson R.G., Courington K.R., et al. Altered motility and bacterial flora after functional end-to-end anastomosis. Surgery. 108:1990;384-391.
26. Arnold J.H., Alevizatos C.A., Cox S.E., et al. Propagation of small bowel migrating motor complex activity fronts varies with anastomosis type. J Surg Res. 51:1991;506-511.
27. Fallimborg J., Pedersen P., Jacobsen B.A. Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease. Dig Dis Sci. 43:1998;702-705.
28. Fallimborg J. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 46:1999;183-196.
29. Hussain F.N., Ajjan R.A., Moustafa M., et al. Mesalazine release from a pH dependent formulation Effect of omeprazole and lactulose co-administration . Br J Pharmacol. 46:1998;173-175.
30. Aparicio-Pages M.N., Vesparget H.W., Hafkenscheid J.C.M., et al. Inhibition of cell mediated cytotoxicity by sulphasalazine Effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity . Gut. 31:1990;1030-1032.
31. Vesparget H.W., Aparicio-Pages M.N., Verver S., et al. Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Scand J Gastroenterol. 26:1991;779-786.
32. Pullman W.E., Doe W.F. IL2 production by intestinal lamina propria cell in normal inflamed and cancer bearing colons. Clin Exp Immunol. 88:1992;132-137.